Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors
AffiliationThe Christie NHS Foundation Trust, Manchester
MetadataShow full item record
CitationTinsley N, Graham DM, Cook N. Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors. Annals of Translational Medicine. 2020;8.
JournalAnnals of Translational Medicine
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
- Authors: Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber RD, Goldhirsch A
- Issue date: 2018 Jun
- Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort.
- Authors: Sun D, Ma J, Wang J, Zhang F, Wang L, Zhang S, Chen G, Li X, Du W, Cui P, Hu Y
- Issue date: 2018
- Immune checkpoint inhibitors in advanced non-small cell lung cancer.
- Authors: Assi HI, Kamphorst AO, Moukalled NM, Ramalingam SS
- Issue date: 2018 Jan 15
- Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.
- Authors: Melosky B, Chu Q, Juergens RA, Leighl N, Ionescu D, Tsao MS, McLeod D, Hirsh V
- Issue date: 2018 Apr
- Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.
- Authors: Chang X, Lu X, Guo J, Teng GJ
- Issue date: 2019 Mar